Skip to main content
. Author manuscript; available in PMC: 2011 Sep 14.
Published in final edited form as: J Clin Psychopharmacol. 2010 Aug;30(4):396–403. doi: 10.1097/JCP.0b013e3181e617a1

Table 4.

Performance on Key Cognitive Indices (mean ± SD), for Responders (Resp) and Non-responders (Non-resp), for each Treatment Arm

Lamotrigine treatment Placebo treatment
Resp (n=7) Non-resp (n=9) Sig. E Resp (n=5) Non-resp (n=11) Sig. E
IED Total errors 22.86 ± 12.46 11.22 ± 7.28 * 1.18 14.6 ± 9.4 15.44 ± 10.51 −0.08
IED Total errors (adjusted) 33.57 ± 24.58 14 ± 15.48 * 0.98 14.6 ± 9.4 15.44 ± 10.51 −0.08
IED Total errors, ID shift 0.43 ± 0.79 0.22 ± 0.44 0.34 3.2 ± 7.16 0.33 ±0.71 0.69
IED Total errors, ED shift 15.14 ± 11.33 4.89 ± 7.3 * 1.11 4.8 ± 5.81 6.11 ± 6.77 −0.20
SST Median correct RT on GO trials 551 ± 196.74 438.78 ± 128.1 0.70 508.4 ± 218.93 486.72 ± 125.61 0.13
SST SSRT 211.55 ± 44.83 164.38 ± 23.83 ** 1.37 294.43 ± 158.18 167.7 ± 51.23 * 1.26
SST Proportion of successful stops 0.54 ± 0.1 0.51 ± 0.04 0.42 0.51 ± 0.21 0.52 ± 0.09 −0.07
SST Direction errors on stop and go trials 3.57 ± 3.69 4 ± 4.9 −0.10 6.6 ± 11.13 3 ± 5.94 0.45

Sig.: Significant difference between responders and non-responders within group,

*

p<0.05,

**

p<0.01 E: Effect size, Cohen’s D, using pooled standard deviation